This curated symposium brought together early-stage health security companies, government agencies, investors, strategic partners, and existing companies supported through BARDA, including BARDA Ventures, Blue Knight, and the CARB-X programs. Over 300 innovators developing breakthrough health security technologies and non-dilutive funders, investors, strategic partners, and numerous startups participated, eager to share their technologies and connect with one another.
The 2024 Innovation Symposium successfully fostered an environment for meaningful connections to advance the development of innovative medical countermeasures (MCMs) in alignment with BARDA’s mission.
Innovators, government partners, investors, and industry leaders in attendance
One-on-one partnering meetings with countless other informal meetings and discussions
Poster
Presentations
Flash Talks
Discussion with BARDA’s Early-Stage Programs and Partners
Discussion with BARDA Divisions Supporting Advanced R&D
Vaccines/Prophylactic Flash Talks
Amplitude Therapeutics, GEn1E, Neuroene, Tiny Cargo, SNIPR BiomeMedical Devices/Diagnostics Flash Talks
Day Zero Diagnostics, Duke, In Diagnostics, Jumpcode, Micron BiomedicalTherapeutics Flash Talks
Cellics, Immunyx, Locus, Specific Biologics, Swaza, Tiba, VedantaEngagement Table Meetings
Poster Session 1
Poster Session 2
Engagement Table Meetings
BARDA Division and Partner Tables